1. Soderstrom N. Puncture of goiters for aspiration biopsy. Acta Med Scand. 1952; 144:237–44.
2. Okui K, Lindberg LG. Aspiration cytology in Lund University Hospital, Sweden. J Jpn Soc Clin Cytol. 1979; 18:105–9.
3. Toriya K. Cytological aspiration biopsy of goiters, especially with reference to their histological and cytological examinations. J Jpn Soc Clin Cytol. 1972; 11:101–14.
Article
4. Toriya K. Fine needle aspiration cytology of the thyroid. Shindantochiryou. 2005; 93:1051–5.
5. Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. New York: Springer;2010.
6. Kakudo K, Kameyama K, Miyauchi A. History of thyroid cytology in Japan and reporting system recommended by the Japan Thyroid Association. J Basic Clin Med. 2013; 2:10–5.
7. Japanese Society of Thyroid Surgery Editorial Committee. General rules for the description of thyroid cancer. 6th ed. Tokyo: Kanahara Publisher;2005.
8. Japan Thyroid Association. Guidelines for clinical practice for the management of thyroid nodules in Japan 2013. Tokyo: Nankodo Co., Ltd;2013.
9. Kakudo K, Kameyama K, Miyauchi A, Nakamura H. Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. Endocr J. 2014; 61:539–52.
10. Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol. 1996; 15:84–9.
11. Takada N, Hirokawa M, Suzuki A, Higuchi M, Kuma S, Miyauchi A. Reappraisal of “cyst fluid only” on thyroid fine-needle aspiration cytology. Endocr J. 2017; 64:759–65.
12. Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016; 40:516–22.
Article
13. Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016; 4:933–42.
Article
14. Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016; 26:144–9.
Article
15. Sugino K, Kameyama K, Ito K. Characteristics and outcome of thyroid cancer patients with indeterminate cytology. J Basic Clin Med. 2015; 4:92–8.
16. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111:306–15.
Article
17. Williams BA, Bullock MJ, Trites JR, Taylor SM, Hart RD. Rates of thyroid malignancy by FNA diagnostic category. J Otolaryngol Head Neck Surg. 2013; 42:61.
Article
18. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26:1–133.
19. Kumagai A, Namba H, Akanov Z, et al. Clinical implications of pre-operative rapid BRAF analysis for papillary thyroid cancer. Endocr J. 2007; 54:399–405.
Article
20. Miyauchi A, Takai S, Morimoto S, et al. Fine needle aspiration of neck tumor. Application of cytological, bacteriological and hormonal examinations. Nihon Geka Gakkai Zasshi. 1983; 84:667–73.
21. Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid. 2007; 17:635–8.
Article